novo nordisk glp-1 promotes new receptor agonist to fight diabetes, obesity < Pharma < Article Novo Nordisk is slashing GLP-1
Description
The focus is on making sure yo
When GLP-1 receptor agonists (GLP-1RAs) were first approved over a decade ago, their primary indication was simple: help people with Type 2 diabetes manage their blood sugar
Novo Nordisk, the manufacturer of Ozempic, announced a plan to reduce its global workforce by approximately 9,000 positions today.
Plus, determine if a GLP-1 medication is right for your health or weight loss journey.
Recent studies...
$195/month
